Implementing Digital Solutions to Improve Oncology Trial Experience & Efficiency

A top-10 pharmaceutical company conducting an oncology clinical trial to evaluate changes in the delivery of existing treatment was looking to improve various inefficiencies associated with its current approach. The treatment being observed in the trial was previously approved for an in-clinic IV but was being tested for the safety and efficacy of an at-home autoinjector.

Specifically, the company was looking to reduce the trial participation burden typically associated with oncology trials, improve site efficiency, improve site and study team experience, and templatize a new approach for future clinical trials of all types.

Uncover how the company was able to overcome study obstacles with a digital software platform.